By Richard A. Lewis, MD
The overall disappointing results of neuroprotective studies thus far should not halt promising research.
By Michael Belkin, MA, MD
By Eric H. Leung, MD, MS; Christopher Rodarte, MD; Felipe A. Medeiros, MD, PHD; and Robert N. Weinreb, MD
An overview of current methods and difficulties and a look at the future.
By Chris A. Johnson, PHD
Several questions come to my mind when dealing with someone who has severe glaucoma.
By George L. Spaeth, MD
Strategies for assisting patients who have lost vision to glaucoma.
By Kara Hanson, OD, FAAO
Research is shedding light on the degeneration of retinal ganglion cells and suggests possible means toward their recovery.
By Jeffery L. Goldberg, MD, PHD
By Gloria P. Fleming, MD
Glaucoma Today asked five physicians to share how they are managing their practices.
By Brian Flowers, MD; George R. Reiss, MD; Adam C. Reynolds, MD; Michael H. Rotberg, MD; and George Shafranov, MD
By Nthan M. Radcliffe, MD
Dr. Wiggs comments on the potential clinical applications as well as the challenges of genetic research in glaucoma.
Investigators identified a linkage signal on chromosome 2p as a major risk factor for primary open-angle glaucoma (POAG) in the Afro-Caribbean population of Barbados, West Indies. The researchers performed linkage analyses i... more >
In a study that appears in the September 2009 online edition of Experimental Eye Research, investigators at the University of Toronto announced their discovery of lymphatic channels in the human ciliary body. Previously, it wa... more >
Results from a cross-sectional study failed to prove that those who use ginkgo biloba are less likely to develop glaucoma. Investigators analyzed results from 30,964 individuals aged 50 years and older who responded to the 2002... more >
SOLX, Inc. (Waltham, MA), announced that it has received FDA clearance for the SOLX 790, a new glaucoma laser designed to perform titanium sapphire laser trabeculoplasty (TLT). The approval came after a multicenter, internation... more >
advertisement
Research is shedding light on the degeneration of retinal ganglion cells and suggests possible means toward their recovery.
by Jeffery L. Goldberg, MD, PHD
An overview of current methods and difficulties and a look at the future.
by Chris A. Johnson, PHD
Several questions come to my mind when dealing with someone who has severe glaucoma.
by George L. Spaeth, MD
The overall disappointing results of neuroprotective studies thus far should not halt promising research.
by Michael Belkin, MA, MD
Strategies for assisting patients who have lost vision to glaucoma.
by Kara Hanson, OD, FAAO